Literature DB >> 4172459

Thyroid hormone transport in the serum of patients with thyrotoxic Graves' disease before and after treatment.

L E Braverman, A E Foster, S H Ingbar.   

Abstract

Multiple indices of thyroid hormone binding have been studied in sera obtained from patients with thyrotoxic Graves' disease, before and after treatment, and in sera from a group of carefully matched normal controls. Specimens from patients with thyrotoxicosis displayed a decrease in the thyroxine (T(4))-binding capacities of T(4)-binding globulin (TBG) and T(4)-binding prealbumin (TBPA), an increase in serum protein-bound iodine (PBI), and an increase in both the proportion and absolute concentration of free T(4). In addition, a smaller than normal proportion of (131)I-labeled T(3) was associated with TBG during filter paper electrophoresis. After treatment of thyroxicosis, the only residual abnormality detected was a very slight persistent decrease in the T(4)-binding capacity of TBPA, which did not appear to influence the overall thyroid hormone-plasma protein interaction significantly, regardless of whether this was assessed under basal conditions or after enrichment of specimens with stable T(4). It is concluded that the persistent abnormalities in the peripheral metabolism of T(4), previously reported to occur in some patients with treated Graves' disease, probably do not stem from residual abnormalities in the transport of T(4) in the plasma but must arise from abnormalities in T(4) accumulation or metabolism within the tissues themselves.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4172459      PMCID: PMC297291          DOI: 10.1172/JCI105827

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  DIFFERENCES IN THE INTERACTION OF TRIIODOTHYRONINE-131-I WITH SERUM PROTEINS IN VITRO.

Authors:  M L MITCHELL; A H BRADFORD; S COLLINS
Journal:  J Clin Endocrinol Metab       Date:  1964-09       Impact factor: 5.958

2.  Thyroxine turnover in euthyroid man with special reference to changes with age.

Authors:  R I GREGERMAN; G W GAFFNEY; N W SHOCK; S E CROWDER
Journal:  J Clin Invest       Date:  1962-11       Impact factor: 14.808

3.  Correlation of the red blood cell uptake of I-131-L-triiodothyronine and thyroxine-binding globulin capacity in man.

Authors:  J N SILVERSTEIN; H L SCHWARTZ; E B FELDMAN; D M KYDO; A C CARTER
Journal:  J Clin Endocrinol Metab       Date:  1962-10       Impact factor: 5.958

4.  Regulation of the peripheral metabolism of the thyroid hormones.

Authors:  S H INGBAR; N FREINKEL
Journal:  Recent Prog Horm Res       Date:  1960

5.  Studies of thyroid function and the peripheral metabolism of I 131-labeled thyroxine in patients with treated Graves disease.

Authors:  S H INGBAR; N FREINKEL
Journal:  J Clin Invest       Date:  1958-11       Impact factor: 14.808

6.  The kinetics of distribution between plasma and liver of 131-I-labeled L-thyroxine in man: observations of subjects with normal and decreased serum thyroxine-binding globulin.

Authors:  R R Cavalieri; G L Searle
Journal:  J Clin Invest       Date:  1966-06       Impact factor: 14.808

7.  Effect of preliminary purification of 131-I-thyroxine on the determination of free thyroxine in serum.

Authors:  G C Schussler; J E Plager
Journal:  J Clin Endocrinol Metab       Date:  1967-02       Impact factor: 5.958

8.  Free thyroxine in human serum: simplified measurement with the aid of magnesium precipitation.

Authors:  K Sterling; M A Brenner
Journal:  J Clin Invest       Date:  1966-01       Impact factor: 14.808

9.  Thyroxine transport in thyrotoxicosis and hypothyroidism.

Authors:  M Inada; K Sterling
Journal:  J Clin Invest       Date:  1967-09       Impact factor: 14.808

10.  Estimation of rapidly exchangeable cellular thyroxine from the plasma disappearance curves of simultaneously administered thyroxine-131-I and albumin-125-I.

Authors:  J H Oppenheimer; G Bernstein; J Hasen
Journal:  J Clin Invest       Date:  1967-05       Impact factor: 14.808

View more
  7 in total

1.  The peripheral metabolism of triiodothyronine in normal subjects and in patients with hyperthyroidism.

Authors:  K A Woeber; R J Sobel; S H Ingbar; K Sterling
Journal:  J Clin Invest       Date:  1970-04       Impact factor: 14.808

2.  Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man.

Authors:  J T Nicoloff; J C Low; J H Dussault; D A Fisher
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

3.  Effects of replacement doses of sodium L-thyroxine on the peripheral metabolism of thyroxine and triiodothyronine in man.

Authors:  L E Braverman; A Vagenakis; P Downs; A E Foster; K Sterling; S H Ingbar
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

4.  Alterations in thyroid hormone economy in patients with hydatidiform mole.

Authors:  V A Galton; S H Inggar; J Jimenez-Fonseca; J M Hershman
Journal:  J Clin Invest       Date:  1971-06       Impact factor: 14.808

5.  Effects of norethandrolone on the transport and peripheral metabolism of thyroxine in patients lacking thyroxine-binding globulin. Observations on the physiological role of thyroxine-binding prealbumin.

Authors:  L E Braverman; T AvRuskin; M J Cullen; A G Vagenakis; S H Ingbar
Journal:  J Clin Invest       Date:  1971-08       Impact factor: 14.808

6.  Hyperthyroidism with normal serum total T4, T3, and thyroid binding protein concentration.

Authors:  J F Caro; N G Sloane; J A Glennon
Journal:  J Clin Pathol       Date:  1980-09       Impact factor: 3.411

7.  A case of thyroxine (T4) toxicosis complicated by thyroid storm with an unusual precipitant.

Authors:  Akolade O Idowu; Oluwaseyitan Andrew Adesegun; Bamikole Osibowale; Theophilus Ajiro; Daniel Ezuduemoih; Ayokunle Osonuga
Journal:  Caspian J Intern Med       Date:  2020
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.